When it comes to quality analytical controls for raw materials, APIs, finished products, and packaging, you need precise results, reliable service, and fast turnarounds. Our well-equipped, state-of-the-art laboratories offer comprehensive quality control testing services according to FDA, EMA, USP, BP, and JP standards, as well as to our clients’ specifications. With our global network of laboratories, you’ll benefit from local service, fast turnaround times, high-quality analytical testing services, and cost-effective API manufacturing. Our comprehensive range of pharmaceutical products includes:

 

Acetylcholinesterase Inhibitors

The following medicines work by preventing an enzyme from breaking down a substance called acetylcholine in the brain, which helps nerve cells communicate with each other.

• Donepezil (Aricept)
• Rivastigmine (Exelon)
• Galantamine (Reminyl)

(Donepezil is also used to treat more severe Alzheimer’s disease).

Recombinant DNA technology involves altering genetic material outside an organism to obtain enhanced and desired characteristics in living organisms or their products. Our unique processes and specialized medical research ensure we consistently deliver cutting-edge medical solutions. This technology includes the insertion of DNA fragments from various sources with a desirable gene sequence via an appropriate vector.

 

Our techniques in recombinant DNA technology, gene therapy, and genetic modifications are used for bioremediation and treating serious diseases. Thanks to our significant advancements and wide range of applications in recombinant DNA technology, we have further streamlined our processes to ensure the most effective treatments for patient use.

At Deira Limited, our expert scientists and bioengineers carry out biosafety testing for:

• Sterility
• Direct Inoculation (EP 2.6.1)
• Filtration method (EP 2.6.1)
• Alternative automated methods
• Endotoxins detection (EP 2.6.14, USP)
• Cytotoxicity testing (ISO 10993-5, USP)
• Pyrogen detection (EP 2.6.30, In vitro testing)
• Bacterial identification
• Vitek2, Apigallery
   
• Virus testing (EP 2.6.16, 5.2.3, ICHQ5A)
   
• In vitro adventitious virus assays
   
• Mycoplasma testing (EP 2.6.7, FDA)
   
• Cell banks and raw materials
   
• Cell-derived harvests and final products
   
• Viral seeds and harvests
   
• Animal tissue and cell-derived products

 

We also conduct purified drug substance testing for “PRP”, supporting the manufacture of biologicals and recombinant proteins. Biosafety testing on monoclonal antibodies, viral vaccines, cell therapies, and gene therapy tests are also carried out by our expert teams.